NEW ORLEANS, April 7, 2014 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company") (NASDAQ GS: QCOR) to Mallinckrodt plc (NYSE: MNK). Under the terms of the proposed transaction, shareholders of Quesctor will receive only $30.00 in cash and 0.897 shares of Mallinckrodt for each share of Questcor common stock that they own, for a total approximate consideration of $86.10 per Questcor share. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( email@example.com) or associate Michael J. Palestina ( firstname.lastname@example.org) toll free at any time at 855-768-1857.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
Kahn Swick & Foti, LLC206 Covington St. Madisonville, LA 70447SOURCE Kahn Swick & Foti, LLC